Cite
HARVARD Citation
Xhaard, A. et al. (2022). The transfusion of non‐prophylactically RH‐KEL1 antigen‐matched red blood cells is feasible in selected myelodysplastic syndrome and acute myeloid leukaemia patients. Vox sanguinis. 117 (5), pp. 693-700. [Online].